Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net loss	$ (454,610)	$ (680,100)
Adjustments to reconcile net loss to net cash used in operating activities:
Net income in equity method investment	(21,580)	(2,746)
Depreciation and amortization	68,455	110,827
Loss on disposal of property, plant and equipment	0	3,607
Accretion of obligation for lease disposal costs	11,328	10,464
Accretion of beneficial conversion feature and debt discount	211,527	23,677
Equity based compensation	29,193	107,063
Changes in operating assets and liabilities:
Accounts receivable	184,854	(107,154)
Prepaids and other assets	164,418	193,364
Inventories	218,811	(45,730)
Accounts payable and accrued liabilities	(215,819)	58,746
Net cash provided by (used in) operating activities	196,577	(327,982)
Cash flows from investing activities:
Restricted certificate of deposit	1,045	(354)
Dividends received from equity method investment	23,714	18,232
Purchase of property, plant and equipment	(8,739)	(137,657)
Net cash provided by (used in) investing activities	16,020	(119,779)
Cash flows from financing activities:
Proceeds from sale of stock	2,439	2,910
Proceeds from issuance of debt	0	1,060,000
Principal payments on notes payable and capital leases	(51,371)	(100,000)
Net cash provided by (used in) financing activities	(48,932)	962,910
Net increase in cash and cash equivalents	163,665	515,149
Cash and cash equivalents at beginning of period	456,374	546,143
Cash and cash equivalents at end of period	620,039	1,061,292
Supplemental disclosure of cash flow activities:
Cash paid for interest	1,891	29,030
Supplemental disclosure of noncash financing and investing transactions:
Increase in equity and decrease in debt for the beneficial conversion feature associated with the convertible debentures	$ 0	$ 75,715